Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancer

Mathematical Biosciences & Engineering(2023)10.3934/mbe.2023783Source: DataRank Database

Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancer is a research paper published in Mathematical Biosciences & Engineering (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (26)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Patrick N. Song ORCID,Kirsten M. Reeves ORCID,Benjamin M. Larimer ORCID,Anna G. Sorace ORCID,Thomas E. Yankeelov ORCID

Live enrichment

PubMed:38052529

National Institutes of Health

Grant: 5U24CA226110-05

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER

National Institutes of Health

Grant: 5T32GM135028-03

UAB Predoctoral Training Grant in Translational and Molecular Sciences

National Institutes of Health

Grant: 5R01CA240589-04

Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging

National Institutes of Health

Grant: 1R01CA276540-01

Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer

goldLicense: http://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (http://creativecommons.org/licenses/by/4.0/) )

https://doi.org/10.3934/mbe.2023783

https://pubmed.ncbi.nlm.nih.gov/38052529

http://dx.doi.org/10.3934/mbe.2023783

https://doaj.org/article/b4a6b342a4404b939a7de0f477b55c1f

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

uncertainty quantificationimmunotherapy modelAdenocarcinomaArticleMiceCell Line, TumorQA1-939Tumor MicroenvironmentAnimalstumor growth modelMisonidazoleHypoxiamousemodel calibrationCell HypoxiaDisease Models, AnimalNitroimidazolesColonic Neoplasms[<sup>18</sup>f]fmiso-petPhosphoramide MustardsImmunotherapyTP248.13-248.65MathematicsBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health